SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001072613-19-000226
Filing Date
2019-07-08
Accepted
2019-07-08 16:10:43
Documents
1
Group Members
DAVID M. MOTTFOREST BASKETTHARRY R. WELLERKRISHNA S. KOLLURIMICHAEL JAMES BARRETTNEA 13 GP, LTDNEA PARTNERS 13, L.P.PATRICK J. KERINSPETER J. BARRISRAVI VISWANATHANSCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 NEW ENTERPRISE ASSOC. 13, LP - EPIZYME, INC. -- SCHEDULE 13D/A (#3E) epizyme-sch13d_18327.htm SC 13D/A 84865
  Complete submission text file 0001072613-19-000226.txt   86684
Mailing Address 1119 ST PAUL STREET BALTIMORE MD 21202
Business Address 1119 ST PAUL STREET BALTIMORE MD 21202 410-244-0115
NEW ENTERPRISE ASSOCIATES 13 LP (Filed by) CIK: 0001452907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9
Type: SC 13D/A

Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Subject) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87481 | Film No.: 19945425
SIC: 2834 Pharmaceutical Preparations